{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:58:04Z","timestamp":1762271884566},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004522","name":"Top Institute Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004522","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejmech.2015.01.063","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T16:27:51Z","timestamp":1422894471000},"page":"121-134","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["When structure\u2013affinity relationships meet structure\u2013kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists"],"prefix":"10.1016","volume":"93","author":[{"given":"Maris","family":"Vilums","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelien J.M.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana","family":"Barmare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouk M.F.","family":"van der Gracht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave C.T.","family":"Bleeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Krenitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Brussee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Stamos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.","family":"Heitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan P.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.01.063_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-1759(02)00414-3","article-title":"Chemokine receptors in inflammation: an overview","volume":"273","author":"D'Ambrosio","year":"2003","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2015.01.063_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1517\/13543784.2011.575359","article-title":"Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments","volume":"20","author":"Kang","year":"2011","journal-title":"Expert Opin. Inv Drug"},{"key":"10.1016\/j.ejmech.2015.01.063_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2015.01.063_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/13543776.16.1.49","article-title":"The CCR2 receptor as a therapeutic target","volume":"16","author":"Feria","year":"2006","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2015.01.063_bib5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/156802610791561255","article-title":"CCR2 antagonists","volume":"10","author":"Struthers","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.01.063_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pain.2013.02.003","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia","volume":"154","author":"Kalliomaki","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2015.01.063_bib7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/13543784.17.9.1267","article-title":"Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases","volume":"17","author":"Kalinowska","year":"2008","journal-title":"Expert Opin. Inv Drug"},{"key":"10.1016\/j.ejmech.2015.01.063_bib8","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejmech.2015.01.063_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant Protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmech.2015.01.063_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2015.01.063_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrd1500","article-title":"Biochemical mechanisms of drug action: what does it take for success?","volume":"3","author":"Swinney","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2015.01.063_bib12","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1021\/jm4011737","article-title":"Structure-kinetic relationships\u2013an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists","volume":"56","author":"Vilums","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.01.063_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0040-4020(01)80922-4","article-title":"Pybop and Pybrop - 2 reagents for the difficult coupling of the Alpha,Alpha-dialkyl amino-acid, Aib","volume":"47","author":"Frerot","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2015.01.063_bib14","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1016\/j.tetlet.2008.06.095","article-title":"Reductive amination with 5-ethyl-2-methylpyridine borane","volume":"49","author":"Burkhardt","year":"2008","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2015.01.063_bib15","unstructured":"P. Zhang, J.C. Kern, E.A. Terefenko, E.J. Trybulski, 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators., in: Patent US2007066628."},{"key":"10.1016\/j.ejmech.2015.01.063_bib16","doi-asserted-by":"crossref","first-page":"10011","DOI":"10.1021\/jo201794k","article-title":"Stereoselective amination of chiral benzylic ethers using chlorosulfonyl isocyanate: total synthesis of (+)-Sertraline","volume":"76","author":"Lee","year":"2011","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2015.01.063_bib17","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1016\/S0040-4039(97)01334-8","article-title":"2,4-dinitrobenzenesulfonamides: a simple and practical method for the preparation of a variety of secondary amines and diamines.","volume":"38","author":"Fukuyama","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2015.01.063_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/mol.113.086850","article-title":"Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2","volume":"84","author":"Zweemer","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.01.063_bib19","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.bmcl.2008.12.050","article-title":"Design, synthesis, and structure-activity relationship of novel CCR2 antagonists","volume":"19","author":"Kothandaraman","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.01.063_bib20","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bmcl.2011.01.015","article-title":"Discovery of INCB10820\/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist","volume":"21","author":"Zheng","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.01.063_bib21","unstructured":"R. Jiao, S.D. Goble, S.G. Mills, G. Morriello, A. Pasternak, L. Yang, C. Zhou, G. Butora, S. Kothandaraman, D. Guiadeen, C. Moyes, Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity., in: Patent WO03093231."},{"key":"10.1016\/j.ejmech.2015.01.063_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1087057112464776","article-title":"Dual-Point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics","volume":"18","author":"Guo","year":"2013","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.ejmech.2015.01.063_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1021\/ml200199c","article-title":"Discovery of INCB8761\/PF-4136309, a potent, selective, and orally bioavailable CCR2 antagonist","volume":"2","author":"Xue","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.01.063_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/ml900009d","article-title":"Discovery of a potent orally bioavailable CCR2 and CCR5 dual antagonist","volume":"1","author":"Pasternak","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.01.063_bib25","doi-asserted-by":"crossref","first-page":"18903","DOI":"10.1021\/ja207494u","article-title":"Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design","volume":"133","author":"Schmidtke","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2015.01.063_bib26","unstructured":"G. Butora, S.D. Goble, A. Pasternak, L. Yang, C. Zhou, C.R. Moyes, Heterocyclic Cyclopentyl Tetrahydroisoquinoline And Tetrahydropyridopyridine Modulators Of Chemokine Receptor Activity., in: Patent WO 2004094371, 2004."},{"key":"10.1016\/j.ejmech.2015.01.063_bib27","unstructured":"C.M. Xue, B.; Feng, H.; Cao, G.; Huang, T.; Zheng, C.; Robinson, D. J.; Han, A., 3-Aminopyrrolidine derivatives as modulators of chemokine receptors., in: Patent WO2004050024."},{"key":"10.1016\/j.ejmech.2015.01.063_bib28","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.4049\/jimmunol.175.8.5370","article-title":"Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344","volume":"175","author":"Brodmerkel","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2015.01.063_bib29","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic-reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T10:28:35Z","timestamp":1537871315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":29,"alternative-id":["S0223523415000847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.01.063","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When structure\u2013affinity relationships meet structure\u2013kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.01.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}